These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4269247)

  • 1. Urinary hydroxyproline and glycosaminoglycan excretion in Down's syndrome.
    Klujber L; Méhes K
    Z Kinderheilkd; 1973; 114(3):205-9. PubMed ID: 4269247
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on acid mucopolysaccharides in urine. 1. On urinary acid mucopolysaccharides from patients with mongolism (Down's syndrome).
    Kamikubo K
    Fukushima J Med Sci; 1965 Dec; 12(3):89-101. PubMed ID: 4223891
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. III. Urinary hydroxyproline and glycosaminoglycan excretion following bone fractures treated in different ways.
    Kustos G; Klujber L; Weisenbach J; Szemlédy F
    Acta Chir Acad Sci Hung; 1979; 20(1):91-101. PubMed ID: 554383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary peptide hydroxyproline and glycosaminoglycan excretion during the early stage of fracture repair in children.
    Kustos G; Klujber L; Pilaszanovich I; Schäfer J; Koltai I
    Acta Chir Acad Sci Hung; 1973; 14(2):119-26. PubMed ID: 4270844
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycosaminoglycan and hydroxyproline excretion in diabetic children.
    Klujber L; Szücs R; Baranyai Z; Gabulya J; Soltész Gy
    Acta Paediatr Acad Sci Hung; 1982; 23(1):27-34. PubMed ID: 6807050
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. I. Urinary hydroxyproline and glycosaminoglycan excretion during fracture repair.
    Kustos G
    Acta Chir Acad Sci Hung; 1979; 20(1):69-78. PubMed ID: 554381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Excretion of glycosaminoglycans and hydroxyproline after surgical interventions on the skeletal system].
    Wilamowski K; Zebrowski W
    Chir Narzadow Ruchu Ortop Pol; 1979; 44(3):245-8. PubMed ID: 467144
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary excretion of beta-aminoisobutyric acid in Down's syndrome and in idiopathic mental retardation.
    Klujber L; Cholnoky P; Méhes K
    Hum Hered; 1969; 19(5):567-72. PubMed ID: 4243810
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical study of Marfan's syndrome].
    Deckers PF
    Presse Med (1893); 1971 Sep; 79(37):1639-40. PubMed ID: 4255353
    [No Abstract]   [Full Text] [Related]  

  • 10. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis.
    Mbuyi JM; Dequeker J; Teblick M; Merlevede M
    J Rheumatol; 1982; 9(4):579-83. PubMed ID: 7131456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo.
    Praticò D; Iuliano L; Amerio G; Tang LX; Rokach J; Sabatino G; Violi F
    Ann Neurol; 2000 Nov; 48(5):795-8. PubMed ID: 11079545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. II. Effects of the type and localisation of fracture on the urinary excretion of hydroxyproline and glycosaminoglycans.
    Kustos G; Weisenbach J; Klujber L
    Acta Chir Acad Sci Hung; 1979; 20(1):79-89. PubMed ID: 554382
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of acid glycosaminoglycans and hydroxyproline in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):215-23. PubMed ID: 734646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
    Bower L; Manley G
    J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neopterin: biopterin ratios in Down's syndrome.
    Cattell RJ; Hamon CG; Corbett JA; Lejeune J; Blair JA
    J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):1015-6. PubMed ID: 2529354
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary excretion of glycosaminoglycans, hydroxyproline and hydroxylysine in rabbits after excessive ingestion of fluoride.
    Jha M; Koacher J; Susheela AK
    Clin Exp Pharmacol Physiol; 1983; 10(5):615-9. PubMed ID: 6641020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of counseling practices at the birth of a child with Down's syndrome.
    Pueschel SM; Murphy A
    Am J Ment Defic; 1977 Jan; 81(4):325-30. PubMed ID: 138363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
    J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal hydroxylysine glycoside excretion in children with ricketts-like diseases].
    Novikov PV; Shilov AV; Daĭkhin EI; Storozhev VL
    Vopr Okhr Materin Det; 1980 Sep; 25(9):53-7. PubMed ID: 7423894
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
    Poulsen JH; Gregersen H
    Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.